| Trial ID: | L3649 |
| Source ID: | NCT00309712
|
| Associated Drug: |
Fenofibrate 160 Mg And Placebo
|
| Title: |
Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type II Diabetes Mellitus|Mixed Dyslipidemia
|
| Interventions: |
DRUG: fenofibrate 160 mg and placebo|DRUG: simvastatin 20 mg and placebo|DRUG: fenofibrate 160 mg and simvastatin 20 mg
|
| Outcome Measures: |
Primary: percent of patients achieving study goal oftriglycerides <200 mg/dL | Secondary: Percent of patients achieving all study goals: LDL-C < 100 mg/dL, HDL-C:40 mg/dL, Triglycerides <200 mg/dL and the Percent of patients achieving non-HDL cholesterol <130 mg/dL
|
| Sponsor/Collaborators: |
Sponsor: Intermountain Health Care, Inc. | Collaborators: Abbott|Merck Sharp & Dohme LLC
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
300
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2002-08
|
| Completion Date: |
2006-09
|
| Results First Posted: |
|
| Last Update Posted: |
2008-08-21
|
| Locations: |
McKay Dee Hospital, Ogden, Utah, 84403, United States|LDS Hospital, Salt Lake City, Utah, 84143, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00309712
|
